Calamos Advisors LLC Clear Point Neuro, Inc. Transaction History
Calamos Advisors LLC
- $14.5 Billion
- Q1 2024
A detailed history of Calamos Advisors LLC transactions in Clear Point Neuro, Inc. stock. As of the latest transaction made, Calamos Advisors LLC holds 16,586 shares of CLPT stock, worth $89,398. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,586Holding current value
$89,398% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CLPT
# of Institutions
82Shares Held
7.47MCall Options Held
83.2KPut Options Held
31.2K-
Black Rock Inc. New York, NY1.47MShares$7.94 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.31MShares$7.05 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA513KShares$2.77 Million0.0% of portfolio
-
Taylor Frigon Capital Management LLC424KShares$2.29 Million1.38% of portfolio
-
State Street Corp Boston, MA416KShares$2.24 Million0.0% of portfolio
About ClearPoint Neuro, Inc.
- Ticker CLPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,488,300
- Market Cap $132M
- Description
- ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain ...